Hotchkis & Wiley Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,018,300
| Closed | -$147M | – | 490 |
|
|
2022
Q1 | $147M | Sell |
2,018,300
-437,140
| -18% | -$31.9M | 0.47% | 59 |
|
|
2021
Q4 | $153M | Sell |
2,455,440
-31,803
| -1% | -$1.98M | 0.48% | 56 |
|
|
2021
Q3 | $147M | Sell |
2,487,243
-82,900
| -3% | -$4.91M | 0.47% | 60 |
|
|
2021
Q2 | $172M | Sell |
2,570,143
-147,497
| -5% | -$9.86M | 0.52% | 55 |
|
|
2021
Q1 | $172M | Sell |
2,717,640
-22,900
| -0.8% | -$1.45M | 0.52% | 53 |
|
|
2020
Q4 | $170M | Buy |
+2,740,540
| New | +$170M | 0.59% | 50 |
|